IRIS Accounts Production v23.2.0.158 10381885 Board of Directors 1.1.22 31.12.22 31.12.22 22.12.23 false true false false true false Auditors Opinion Ordinary 0.01000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh103818852021-12-31103818852022-12-31103818852022-01-012022-12-31103818852020-12-31103818852021-01-012021-12-31103818852021-12-3110381885ns10:Originalns15:EnglandWales2022-01-012022-12-3110381885ns14:PoundSterlingns10:Original2022-01-012022-12-3110381885ns10:Originalns10:Director12022-01-012022-12-3110381885ns10:Original2022-01-012022-12-3110381885ns10:Original2022-12-3110381885ns10:Originalns10:PrivateLimitedCompanyLtd2022-01-012022-12-3110381885ns10:Originalns10:SmallEntities2022-01-012022-12-3110381885ns10:Originalns10:Audited2022-01-012022-12-3110381885ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-01-012022-12-3110381885ns10:SmallCompaniesRegimeForAccountsns10:Original2022-01-012022-12-3110381885ns10:Originalns10:FullAccounts2022-01-012022-12-3110381885ns10:Originalns10:OrdinaryShareClass12022-01-012022-12-3110381885ns10:Originalns10:Director22022-01-012022-12-3110381885ns10:Originalns10:Director32022-01-012022-12-3110381885ns10:Originalns10:Director42022-01-012022-12-3110381885ns10:Originalns10:RegisteredOffice2022-01-012022-12-3110381885ns10:Original2021-12-3110381885ns10:Originalns5:CurrentFinancialInstruments2022-12-3110381885ns10:Originalns5:CurrentFinancialInstruments2021-12-3110381885ns5:ShareCapitalns10:Original2022-12-3110381885ns5:ShareCapitalns10:Original2021-12-3110381885ns10:Originalns5:SharePremium2022-12-3110381885ns10:Originalns5:SharePremium2021-12-3110381885ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-12-3110381885ns10:Originalns5:RetainedEarningsAccumulatedLosses2021-12-3110381885ns10:Original2021-01-012021-12-3110381885ns10:Originalns5:PlantMachinery2021-12-3110381885ns10:Originalns5:PlantMachinery2022-01-012022-12-3110381885ns10:Originalns5:PlantMachinery2022-12-3110381885ns10:Originalns5:PlantMachinery2021-12-3110381885ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-12-3110381885ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2021-12-3110381885ns10:Originalns10:OrdinaryShareClass12022-12-3110381885ns10:Originalns5:RetainedEarningsAccumulatedLosses2021-12-3110381885ns10:Originalns5:SharePremium2021-12-3110381885ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-01-012022-12-31
REGISTERED NUMBER: 10381885 (England and Wales)



Financial Statements for the Year Ended 31 December 2022

for

Engage In-Health Limited

Engage In-Health Limited (Registered number: 10381885)

Contents of the Financial Statements
for the Year Ended 31 December 2022










Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 3


Engage In-Health Limited

Company Information
for the Year Ended 31 December 2022







DIRECTORS: Mr J Bailey
Mr K Kish
Mr E Mitzen
Mr S Patel



REGISTERED OFFICE: 71-75 Shelton Street
Covent Garden
London
WC2H 9JQ



REGISTERED NUMBER: 10381885 (England and Wales)



SENIOR STATUTORY AUDITOR: Alan Kaye FCA



AUDITORS: BBK Partnership
Chartered Accountants
& Statutory Auditors
1 Beauchamp Court
10 Victors Way
Barnet
Hertfordshire
EN5 5TZ

Engage In-Health Limited (Registered number: 10381885)

Statement of Financial Position
31 December 2022

31.12.22 31.12.21
Notes £    £   
FIXED ASSETS
Tangible assets 4 9,648 10,770

CURRENT ASSETS
Debtors 5 2,941,760 986,899
Cash at bank 1,272,727 1,128,371
4,214,487 2,115,270
CREDITORS
Amounts falling due within one year 6 (2,236,121 ) (1,107,961 )
NET CURRENT ASSETS 1,978,366 1,007,309
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,988,014

1,018,079

CAPITAL AND RESERVES
Called up share capital 7 111 111
Share premium 8 97,378 97,378
Retained earnings 8 1,890,525 920,590
SHAREHOLDERS' FUNDS 1,988,014 1,018,079

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 20 December 2023 and were signed on its behalf by:





Mr K Kish - Director


Engage In-Health Limited (Registered number: 10381885)

Notes to the Financial Statements
for the Year Ended 31 December 2022


1. STATUTORY INFORMATION

Engage In-Health Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The financial statements are presented in sterling which is the functional currency of the company and rounded to the nearest £1.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Turnover is recognised either during the provision of services or the commencement of contract. Turnover amounts are invoices in arrears, with amounts not invoiced for periods before the balance sheet date
recorded as accrued income. Turnover is recognised as gross, as the company dares the risk of supply.

Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant and machinery - Straight line 3 - 5 years

Engage In-Health Limited (Registered number: 10381885)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2022


2. ACCOUNTING POLICIES - continued

Financial instruments
Cash and cash equivalents
Cash and cash equivalents comprises cash on hand and all deposits, and other short-term highly liquid
investments that are readily convertible to a known amount of cash and are subject to and insignificant risk of change in value.

Trade debtors
Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary
course of business. Trade debtors are recognised initially at the transaction price. They are subsequently
measured at amortised cost using the effective interest method less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of
business from suppliers. Accounts payables are classified as current liabilities of the company does not have an unconditional right at the end of the reporting period to refer settlements of the creditor for at least twelve
months after the reporting date. If there is an unconditional right to defer settlements for at least twelve months after the reporting date they are presented as non-current liabilities. Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the statement of financial position date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Engage In-Health Limited (Registered number: 10381885)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2022


2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Provision
Provisions are recognised when the company has a present obligation (legal or constructive) as a result of a past event, it is probable that the company will be required to settle the obligation, and a reliable estimate can be made of the amount of the obligation. The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the end of the reporting period, taking into account the risks and uncertainties surrounding the obligation. Where the effect of the time value of money is material, the amount expected to be required to settle the obligation is recognised at present value using a pre-tax discount rate. The unwinding of the discount is recognised as a finance cost in profit or loss in the period it arises.

Employee benefits
When employees have rendered service to the company, short-term employee benefits to which the employees are entitled are recognised at the undiscounted amount expected to be paid in exchange for that service.

Loans and borrowings
Loans and borrowings are initially recognised at the transaction price including transaction costs. Subsequently, they are measured at amortised cost using the effective interest rate method, less impairment. If an arrangement constitutes a finance transaction it is measured at present value.

Impairment
Assets not measured at fair value are reviewed for any indication that the asset may be impaired at each balance sheet date. If such indication exists, the recoverable amount of the asset, or the asset's cash generating unit, is estimated and compared to the carrying amount. Where the carrying amount exceeds its recoverable amount, an impairment loss is recognised in profit or loss unless the asset is carried at a revalued amount where the impairment loss is a revaluation decrease.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 21 (2021 - 15 ) .

Engage In-Health Limited (Registered number: 10381885)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2022


4. TANGIBLE FIXED ASSETS
Plant and
machinery
£   
COST
At 1 January 2022 23,877
Additions 3,448
At 31 December 2022 27,325
DEPRECIATION
At 1 January 2022 13,107
Charge for year 4,570
At 31 December 2022 17,677
NET BOOK VALUE
At 31 December 2022 9,648
At 31 December 2021 10,770

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.22 31.12.21
£    £   
Trade debtors 1,830,667 979,399
Amounts owed by group undertakings 1,036,502 -
Other debtors 7,500 7,500
Accrued revenue 64,210 -
Prepayments 2,881 -
2,941,760 986,899

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.22 31.12.21
£    £   
Trade creditors 69,978 430,217
Tax (160,825 ) (228,000 )
Social security and other taxes - 116,345
VAT 215,087 85,250
Other creditors 2,020,042 684,643
Accrued expenses 91,839 19,506
2,236,121 1,107,961

Engage In-Health Limited (Registered number: 10381885)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2022


7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.12.22 31.12.21
value: £    £   
11,112 Ordinary 1p 111 111

8. RESERVES
Retained Share
earnings premium Totals
£    £    £   

At 1 January 2022 920,590 97,378 1,017,968
Profit for the year 969,935 969,935
At 31 December 2022 1,890,525 97,378 1,987,903

9. DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

Alan Kaye FCA (Senior Statutory Auditor)
for and on behalf of BBK Partnership

10. RELATED PARTY DISCLOSURES

Included within other debtors is £1,036,502 being receivable from Fingerpaint Marketing Inc., the ultimate parent company. The amount is receivable within one year and no interest is being charged.

Directors and key management personnel have not been remunerated for their services to the company. However, the directors and key management personal are remunerated by other related undertakings for their services. It is not possible to separately identify the amounts attributable for services rendered to the company.

11. PARENT COMPANY

The directors regards Fingerpaint Marketing Inc. incorporated in the USA, as the immediate parent company and the ultimate parent company and the ultimate controlling party.

The smallest and the largest group in which the results of the company are consolidated is Fingerpaint Marketing Inc., whose financial statements are publically available at its registered office.

The consolidated financial statements of the group are available to the public and may be obtained from Fingerpaint Marketing Inc. 18 Division Street, Suite 212, Saratoga Springs, NY 12866, USA

12. CHARGES

A fixed and floating charge in favour of Midcap Financial Trust have been registered over the assets of the company.